Chemed PE Ratio 2010-2025 | CHE

Current and historical p/e ratio for Chemed (CHE) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Chemed PE ratio as of June 04, 2025 is 26.13.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Chemed PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-04 561.64 27.36
2025-03-31 614.78 $20.53 29.95
2024-12-31 528.85 $19.91 26.56
2024-09-30 599.36 $19.79 30.29
2024-06-30 540.66 $19.72 27.42
2024-03-31 639.18 $18.58 34.40
2023-12-31 581.86 $17.92 32.47
2023-09-30 516.77 $16.15 32.00
2023-06-30 538.20 $15.00 35.88
2023-03-31 533.93 $15.89 33.60
2022-12-31 506.42 $16.53 30.64
2022-09-30 432.80 $17.21 25.15
2022-06-30 464.98 $17.98 25.86
2022-03-31 501.42 $17.09 29.34
2021-12-31 523.28 $16.88 31.00
2021-09-30 459.72 $19.03 24.16
2021-06-30 468.62 $18.62 25.17
2021-03-31 453.81 $20.12 22.56
2020-12-31 525.25 $19.49 26.95
2020-09-30 473.38 $16.49 28.71
2020-06-30 444.23 $15.91 27.92
2020-03-31 426.34 $13.98 30.50
2019-12-31 431.99 $13.30 32.48
2019-09-30 410.34 $12.60 32.57
2019-06-30 354.33 $12.10 29.28
2019-03-31 314.01 $12.29 25.55
2018-12-31 277.66 $12.25 22.67
2018-09-30 312.95 $12.24 25.57
2018-06-30 314.84 $11.31 27.84
2018-03-31 266.72 $6.69 39.87
2017-12-31 237.29 $5.81 40.84
2017-09-30 197.05 $4.50 43.79
2017-06-30 199.18 $3.99 49.92
2017-03-31 177.68 $6.82 26.05
2016-12-31 155.78 $6.49 24.00
2016-09-30 136.74 $6.27 21.81
2016-06-30 131.89 $6.30 20.93
2016-03-31 130.81 $6.37 20.54
2015-12-31 144.39 $6.32 22.85
2015-09-30 128.45 $6.31 20.36
2015-06-30 125.97 $6.05 20.82
2015-03-31 114.52 $5.86 19.54
2014-12-31 101.16 $5.58 18.13
2014-09-30 98.31 $5.15 19.09
2014-06-30 89.35 $4.70 19.01
2014-03-31 85.08 $4.11 20.70
2013-12-31 72.71 $4.16 17.48
2013-09-30 67.67 $4.28 15.81
2013-06-30 68.36 $4.41 15.50
2013-03-31 75.29 $4.74 15.88
2012-12-31 64.41 $4.63 13.91
2012-09-30 64.88 $4.54 14.29
2012-06-30 56.43 $4.51 12.51
2012-03-31 58.36 $4.35 13.42
2011-12-31 47.56 $4.13 11.52
2011-09-30 50.90 $3.80 13.39
2011-06-30 60.51 $3.67 16.49
2011-03-31 61.38 $3.55 17.29
2010-12-31 58.40 $3.55 16.45
2010-09-30 52.26 $3.35 15.60
2010-06-30 49.99 $3.28 15.24
2010-03-31 49.65 $3.22 15.42
2009-12-31 43.70 $3.23 13.53
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.315B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.379B 19.10
Encompass Health (EHC) United States $12.248B 25.96
DaVita (DVA) United States $10.267B 14.44
Elanco Animal Health (ELAN) United States $6.685B 14.32
Option Care Health (OPCH) United States $5.191B 23.14
RadNet (RDNT) United States $4.404B 279.52
Amedisys (AMED) United States $3.101B 20.86
LifeStance Health (LFST) United States $2.318B 0.00
Addus HomeCare (ADUS) United States $2.073B 22.76
Astrana Health (ASTH) United States $1.412B 34.99
U.S Physical Therapy (USPH) United States $1.124B 29.01
Aveanna Healthcare Holdings (AVAH) United States $1.079B 61.44
Pennant (PNTG) United States $1.002B 36.80
Atai Life Sciences (ATAI) Germany $0.471B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.043B 0.00
Daxor (DXR) United States $0.042B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00